Company Encyclopedia
View More
name
Rendu Biotechnology
688193.SH
Shanghai Rendu Biotechnology Co., Ltd. engages in the development and promotion of RNA molecular diagnostic technology and products. The company offers products in the areas of reproductive health, respiratory diseases, enterovirus, food safety, and blood infectious diseases, as well as automatic nucleic acid detection and analysis system. The company was founded in 2007 and is based in Shanghai, China.
337.57 B
688193.SHMarket value -Rank by Market Cap -/-

Financial Score

26/12/2025 Update
C
Health Care SuppliesIndustry
Industry Ranking35/41
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE-0.59%D
    • Profit Margin-3.30%D
    • Gross Margin79.09%A
  • Growth ScoreD
    • Revenue YoY-6.80%D
    • Net Profit YoY-125.71%E
    • Total Assets YoY-1.50%D
    • Net Assets YoY-0.96%D
  • Cash ScoreE
    • Cash Flow Margin-3032.41%E
    • OCF YoY-6.80%D
  • Operating ScoreD
    • Turnover0.17D
  • Debt ScoreA
    • Gearing Ratio7.25%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Rendu Biotechnology: Net profit of 2.038 million yuan in the first half of 2025, a year-on-year decrease of 52.94%

    Rendu Biotechnology announced that in the first half of 2025, operating revenue was 81.2425 million yuan, a year-on-year decrease of 6.27%. Net profit was 2.038 million yuan, a year-on-year decrease of 52.94%

    Zhitong·
    SH
    688193
    +0.17%
    Zhitong·
    SH
    688193
    +0.17%

    Rendu Biotechnology obtained a medical device registration certificate

    According to the Zhitong Finance APP, Rendu Biotechnology announced that its product, the Hepatitis B Virus Nucleic Acid Detection Kit (DNA Capture Probe Method), has obtained a medical device registration certificate

    Zhitong·
    SH
    688193
    +0.17%
    Zhitong·
    SH
    688193
    +0.17%

    Rendu Biotechnology: The shareholding ratio of the controlling shareholder CCF has decreased to 4.99%

    Rendu Biotechnology announced that its controlling shareholder and actual controller CENTRAL CHIEF LIMITED reduced its holdings by 500,000 shares through a block trade, accounting for a reduction ratio of 1.25%, with a reduction price of RMB 33.45 per share. After the transfer, CCF's shareholding ratio decreased from 6.24% to 4.99%. This reduction will not result in a change in the company's controlling shareholder or actual controller. The transferees include Nord Fund Management Co., Ltd., Caitong Fund Management Co., Ltd., and GF Securities Co., Ltd

    Zhitong·
    SH
    688193
    +0.17%
    Zhitong·
    SH
    688193
    +0.17%

    Rendu Biotechnology shareholder CENTRAL CHIEF LIMITED intends to inquire about the transfer of 1.25% of the company's shares

    According to the Zhitong Finance APP, Rendu Biotechnology disclosed the shareholder inquiry transfer plan, with the participating shareholder being CENTRAL CHIEF LIMITED, intending to transfer a total of 500,000 shares, accounting for 1.25% of the company's total share capital

    Zhitong·
    SH
    688193
    +0.17%
    Zhitong·
    SH
    688193
    +0.17%

    Overview of the lifting of restrictions on the sale of A-shares by Zhitong | March 31

    On March 31, 16 listed companies had their restricted shares unlocked, with a total market value of approximately 5.059 billion yuan. The unlocking situation includes: SANY Heavy Industry (600031) 10.7622 million shares, Hainan Mining (601969) 1.7289 million shares, YINGHE TECHNOLOGY (300457) 1.0847 million shares, Allwinner Technology (300458) 213,000 shares, EMTEK (300938) 137,700 shares, Tainco (301263) 15.7 million shares, NANJING SHENGHANG SHIPPING (001205) 196,000 shares, Fantawild (301313) 1.18 million shares, Xinghua New Material (301077) 7.713 million shares, Jiangxi Hungpai New Material (605366) 746,200 shares, Xueqi Electric (001387) 5.4 million shares, Ailong Technology (688329) 23.055 million shares, Rendu Biotechnology (688193) 1.3108 million shares, Rongchang Biotechnology (688331) 1.36 million shares, Rilian Technology (688531) 1.5955 million shares, and Xinyu Ren (688573) 1.5568 million shares

    Zhitong·
    SH
    601969
    +10.02%
    SZ
    300457
    +0.67%
    SZ
    300938
    +0.77%
    Zhitong·
    SH
    601969
    +10.02%
    SZ
    300457
    +0.67%
    SZ
    300938
    +0.77%
    © 2025 Longbridge｜Disclaimer